MRI-Guided Treatment Strategy Not Advised for Patients With RA in Remission

A long-term observational extension study found that a magnetic resonance imaging (MRI)-guided treat-to-target (T2T) strategy did not significantly improve outcomes for patients with rheumatoid arthritis (RA) who were in remission. The study compared an MRI-guided T2T strategy with a conventional T2T strategy focused on achieving clinical remission over 5 years. Results showed no significant difference in remission rates or radiographic progression between the two groups. Patients in the MRI group had lower pain scores and were more likely to receive biological treatments. However, limitations included a small sample size and potential bias from the observational design.

Source link

error: Content is protected !!